ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 82 filers reported holding ELEVATION ONCOLOGY INC in Q2 2024. The put-call ratio across all filers is 3.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,612,707 | -36.8% | 597,299 | +20.1% | 0.92% | -20.3% |
| Q1 2024 | $2,551,144 | +855.3% | 497,299 | 0.0% | 1.16% | +642.9% |
| Q4 2023 | $267,050 | -19.0% | 497,299 | 0.0% | 0.16% | -41.4% |
| Q3 2023 | $329,510 | -56.4% | 497,299 | 0.0% | 0.27% | -62.1% |
| Q2 2023 | $755,894 | – | 497,299 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $7,654,257 | 3.31% |
| venBio Partners LLC | 2,434,255 | $6,572,489 | 2.84% |
| Velan Capital Investment Management LP | 597,299 | $1,612,707 | 0.92% |
| Exome Asset Management LLC | 369,322 | $997,170 | 0.87% |
| Logos Global Management LP | 3,850,000 | $10,395,000 | 0.84% |
| TANG CAPITAL MANAGEMENT LLC | 3,060,000 | $8,262,000 | 0.84% |
| Palo Alto Investors LP | 1,800,106 | $4,860,286 | 0.56% |
| Darwin Global Management, Ltd. | 1,916,290 | $4,809,888 | 0.56% |
| Ghost Tree Capital, LLC | 600,000 | $1,620,000 | 0.51% |
| Affinity Asset Advisors, LLC | 1,468,825 | $3,965,828 | 0.46% |